# Autologous Stem Cell Study for Adult TBI (Phase 2b)

> **NCT02525432** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 37 (actual)

## Conditions studied

- Brain Injuries, Traumatic
- Brain Injuries, Acute
- TBI (Traumatic Brain Injury)

## Interventions

- **BIOLOGICAL:** Placebo Infusion
- **BIOLOGICAL:** Autologous BMMNC Infusion

## Key facts

- **NCT ID:** NCT02525432
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11-21
- **Primary completion:** 2024-07
- **Final completion:** 2025-01
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525432, "Autologous Stem Cell Study for Adult TBI (Phase 2b)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02525432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*